Department of Endocrinology, Greenlane Clinical Centre and Auckland City Hospital, Auckland, New Zealand.
Clin Endocrinol (Oxf). 2014 Jan;80(1):80-4. doi: 10.1111/cen.12253. Epub 2013 Jun 20.
Localization of small insulinomas may be difficult. Selective pancreatic arterial injection of calcium with hepatic venous insulin measurement (SACST) has been used for this purpose, but can rarely cause hypoglycaemia. Two low-dose concentrations of calcium, 0·25 and 0·1 of the usual concentration used for the test, have been compared for sensitivity of localization and safety.
Selective pancreatic arterial injection of calcium with hepatic venous insulin measurement was performed at calcium concentrations of 0·0025 (Protocol A) and 0·00625 (Protocol B) mEq calcium per kg. The standard concentration is 0·025 mEq/kg.
Twenty one successive patients with biochemical evidence of insulinoma were studied.
Using surgical localization as the gold standard, Protocol A had a sensitivity of 91% and Protocol B 75% for correct localization. The false-positive localization rate was 16%. No hypoglycaemia was observed. These results compare favourably with published data using the standard calcium concentration. Selective pancreatic arterial injection of calcium with hepatic venous insulin measurement was superior to localization by noninvasive imaging; in seven cases, SACST was correct when conventional imaging was negative (five) or false positive (two).
Low concentrations of calcium are effective and safe when performing SACST for localization of insulinoma.
小胰岛素瘤的定位可能较为困难。为此目的,已经使用了选择性胰腺动脉钙注射伴肝静脉胰岛素测量(SACST),但很少会引起低血糖。本研究比较了两种低剂量的钙浓度(测试中常用浓度的 0.25 和 0.1)在定位敏感性和安全性方面的差异。
在钙浓度为 0.0025(方案 A)和 0.00625(方案 B)mEq/kg 时,进行了选择性胰腺动脉钙注射伴肝静脉胰岛素测量。标准浓度为 0.025 mEq/kg。
21 例连续的有胰岛素瘤生化证据的患者参与了本研究。
以手术定位为金标准,方案 A 的正确定位敏感性为 91%,方案 B 为 75%。假阳性定位率为 16%。未观察到低血糖。这些结果与使用标准钙浓度的已发表数据相比具有优势。与非侵入性成像相比,选择性胰腺动脉钙注射伴肝静脉胰岛素测量在胰岛素瘤定位方面更具优势;在 7 例中,SACST 在常规成像阴性(5 例)或假阳性(2 例)时是正确的。
在进行 SACST 定位胰岛素瘤时,低钙浓度是有效且安全的。